Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Complement activation at the interface between adipocytes and cancer cells drives tumor progression
Indexado
WoS WOS:001452442800001
Scopus SCOPUS_ID:105000939760
DOI 10.1172/JCI.INSIGHT.184935
Año 2025
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



The omentum is the primary site of metastasis for ovarian cancer (OC). Interactions between cancer cells and adipocytes drive an invasive and prometastatic phenotype. Here we studied cancer cell- adipocyte crosstalk by using a direct coculture model with immortalized human visceral nondiabetic pre-adipocytes (VNPADs) and OC cells. We demonstrated increased proliferation, invasiveness, and resistance to cisplatin of cocultured compared with monocultured OC cells. RNA sequencing of OC cells from coculture versus monoculture revealed significant transcriptomic changes, identifying over 200 differentially expressed genes common to OVCAR5 and OVCAR8 cell lines. Enriched pathways included PI3K/AKT and complement activation. Lipid transfer into OC cells from adipocytes induced upregulation of complement C3 and C5 proteins. Inhibiting C3 or C5 reversed the invasive phenotype and C3 knockdown reduced tumor progression in vivo. Increased C3 expression was observed in omental implants compared with primary ovarian tumors and C3 secretion was higher in OC ascites from high-BMI versus low-BMI patients. C3 upregulation in OC cells involved activation of the ATF4-mediated integrated stress response (ISR). Overall, adipocyte-cancer cell interactions promoted invasiveness and tumorigenesis via lipid transfer, activating the ISR, and upregulating complement proteins C3 and C5.

Revista



Revista ISSN
Jci Insight 2379-3708

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Medicine, Research & Experimental
Scopus
Medicine (All)
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Valdivia, Andres - NORTHWESTERN UNIV - Estados Unidos
2 Isac, Ana Maria - NORTHWESTERN UNIV - Estados Unidos
3 Cardenas, Horacio - NORTHWESTERN UNIV - Estados Unidos
4 Zhao, Guangyuan - NORTHWESTERN UNIV - Estados Unidos
5 Zhang, Yaqi - NORTHWESTERN UNIV - Estados Unidos
6 Huang, Hao - NORTHWESTERN UNIV - Estados Unidos
7 Wei, Jian-Jun - NORTHWESTERN UNIV - Estados Unidos
Northwestern University Feinberg School of Medicine - Estados Unidos
8 Cuello-Fredes, Mauricio - Pontificia Universidad Católica de Chile - Chile
9 Kato, Sumie - Pontificia Universidad Católica de Chile - Chile
10 Gomez-Valenzuela, Fernan - Pontificia Universidad Católica de Chile - Chile
11 Gourronc, Francoise - UNIV IOWA - Estados Unidos
University of Iowa Carver College of Medicine - Estados Unidos
12 Klingelhutz, Aloysius - UNIV IOWA - Estados Unidos
University of Iowa Carver College of Medicine - Estados Unidos
13 Matei, Daniela - NORTHWESTERN UNIV - Estados Unidos
Jesse Brown VA Med Ctr - Estados Unidos
Northwestern University Feinberg School of Medicine - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
NIH
National Institutes of Health
Department of Defense
National Cancer Institute
U.S. Department of Veterans Affairs
U.S. Department of Defense
Office of the Provost
Office for Research
Northwestern University Information Technology
NCI
Northwestern University
University of Texas MD Anderson Cancer Center
US Department of Veterans Affairs
NCI Cancer Center
Ovarian Cancer Research Alliance
Nikon Imaging Center
Office of the Provost, University of South Carolina
Ovarian Cancer Research Alliance postdoctoral fellowship
Wales endowed Professorship from the Lurie Cancer Center
National Cancer Institute (NCI) grant CCSG
Robert H. Lurie Comprehensive Cancer Center
Center for Advanced Microscopy

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This research was supported by funding from the US Department of Veterans Affairs (grant BX006012) , the Department of Defense (grant W81XWH-21-1-0378) , the Diana Princess of Wales endowed Professorship from the Lurie Cancer Center (to DM) , and an Ovarian Cancer Research Alliance postdoctoral fellowship (to AV) . Tumor specimens were procured through the Pathology Core and sequencing was performed in the NUSeq Core supported by National Cancer Institute (NCI) grant CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Flow cytometry analyses were performed in the Northwestern University-Flow Cytometry Core Facility and histology services were provided by the Northwestern University Mouse Histol-ogy and Phenotyping Laboratory supported by NCI Cancer Center Support grant CA060553. Imaging was performed in the Center for Advanced Microscopy/Nikon Imaging Center (CAM) at Northwestern University supported by NCI grant CA060553. This research was supported in part through the computational resources and staff contributions provided for the Quest high-performance computing facility at Northwestern University, which is jointly supported by the Office of the Provost, the Office for Research, and Northwestern University Information Technology. The Functional Proteomics RPPA Core was supported in part by The University of Texas MD Anderson Cancer Center, which is supported by NIH grants P30CA016672 and R50CA221675. The graphical abstract was created in BioRender (https://BioRender.com /s53m632) .
This research was supported by funding from the US Department of Veterans Affairs (grant BX006012), the Department of Defense (grant W81XWH-21-1-0378), the Diana Princess of Wales endowed Professorship from the Lurie Cancer Center (to DM), and an Ovarian Cancer Research Alliance postdoctoral fellowship (to AV). Tumor specimens were procured through the Pathology Core and sequencing was performed in the NUSeq Core supported by National Cancer Institute (NCI) grant CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Flow cytometry analyses were performed in the Northwestern University - Flow Cytometry Core Facility and histology services were provided by the Northwestern University Mouse Histology and Phenotyping Laboratory supported by NCI Cancer Center Support grant CA060553. Imaging was performed in the Center for Advanced Microscopy/Nikon Imaging Center (CAM) at Northwestern University supported by NCI grant CA060553. This research was supported in part through the computational resources and staff contributions provided for the Quest high-performance computing facility at Northwestern University, which is jointly supported by the Office of the Provost, the Office for Research, and Northwestern University Information Technology. The Functional Proteomics RPPA Core was supported in part by The University of Texas MD Anderson Cancer Center, which is supported by NIH grants P30CA016672 and R50CA221675. The graphical abstract was created in BioRender (https://BioRender.com/s53m632).

Muestra la fuente de financiamiento declarada en la publicación.